|
Study
|
Year
|
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
Total Scores
|
|---|
|
Chen Ya-ke
|
2011
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Dong Yu-fu
|
2005
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Blinder, JJ
|
2017
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
8
|
|
Fuhrman, DY
|
2019
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Garcia, RU
|
2020
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
7
|
|
Gil-Ruiz Gil-Esparza
|
2014
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Hirano, D
|
2017
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Huggins, N
|
2014
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
6
|
|
Joffe, R
|
2018
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
8
|
|
Kim, J
|
2020
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
6
|
|
Kimura, S
|
2018
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Kumar, TK
|
2016
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
6
|
|
Kwiatkowski, DM
|
2017
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
8
|
|
Lee, SH
|
2017
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Li, S
|
2011
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Madsen, NL
|
2017
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Mah, KE
|
2018
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Meersch, M
|
2014
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Miklaszewska, M
|
2013
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Park, SK
|
2016
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Piggott, KD
|
2015
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Ricci, Z
|
2012
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
5
|
|
Ruf, B
|
2015
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Sugimoto, K
|
2016
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
7
|
|
Tanyildiz, M
|
2017
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Taylor, ML
|
2013
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
7
|
|
Toth, R
|
2012
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Ueno, K
|
2020
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
|
Van Driest, SL
|
2018
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
8
|
|
Zheng, J
|
2013
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
6
|
- A: Define the source of information (survey, record review); B: List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications; C: Indicate time period used for identifying patients; D: Indicate whether or not subjects were consecutive if not population-based; E: Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants; F: Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements); G: Explain any patient exclusions from analysis; H:Describe how confounding was assessed and/or controlled; I: If applicable, explain how missing data were handled in the analysis; J: Summarize patient response rates and completeness of data collection; K: Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained
